selected scholarly activity
-
conferences
- P114 Repeat mismatch in renal transplantation: Is the original source of repeat mismatch more predictive than cPRA for antibody response post transplant?. Human Immunology. 137-137. 2017
- P234 Typing challenges associated with mixed chimerism. Human Immunology. 227-227. 2017
- Does Bioimpedance Analysis Predict Volume Overload States And Clinically Relevant Outcomes In Septic Intensive Care Unit Patients? A Prospective Observational Study (biovision). American Journal of Respiratory and Critical Care Medicine. 2017
- Donate-Pilot Study. American Journal of Respiratory and Critical Care Medicine. 2017
- Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study. Blood. 90-90. 2016
- Cancer, chronic kidney disease and thrombosis. European Heart Journal. 784-784. 2016
- Assessment of low molecular weight heparin accumulation in patients with chronic kidney disease: results from the TRIVET study. Journal of Thrombosis and Haemostasis. 19-19. 2016
- Cancer, Chronic Kidney Disease and Thrombosis. Journal of Thrombosis and Haemostasis. 79-79. 2016
- P128. Human Immunology. 138-138. 2014
- Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials. Journal of Clinical Oncology. 4008-4008. 2008
- Immunohistochemistry for deficiency of mismatch repair proteins MLH1, MSH2 and MSH6 identifies colorectal carcinomas with high-frequency microsatellite instability. Laboratory Investigation. 135A-135A. 2002
- Immunohistochemistry for deficiency of mismatch repair proteins MLH1, MSH2 and MSH6 identifies colorectal carcinomas with high-frequency microsatellite instability. Modern Pathology. 135A-135A. 2002
-
journal articles
- Canada-DONATE study protocol: a prospective national observational study of the medical management of deceased organ donors. BMJ Open. 7:e018858-e018858. 2017
- Thrombosis and anticoagulation in the setting of renal or liver disease. Hematology. American Society of Hematology. Education Program. 2016:188-195. 2016
- Assessment of Postresuscitation Volume Status by Bioimpedance Analysis in Patients with Sepsis in the Intensive Care Unit: A Pilot Observational Study. Canadian Respiratory Journal. 2016:1-8. 2016
- Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Medicine. 41:1561-1571. 2015
- The impact of patient preference on dialysis modality and hemodialysis vascular access. BMC Nephrology. 15:38. 2014
- The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index. Journal of Clinical Epidemiology. 67:622-628. 2014
- Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?. Canadian Journal of Cardiology. 27:146-151. 2011
- Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer. Journal of Clinical Oncology. 28:3219-3226. 2010
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment Effects<subtitle>Systematic Review and Meta-regression Analysis</subtitle>. Journal of the American Medical Association (JAMA). 303:1180-1180. 2010
- Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review. Journal of Critical Care. 24:197-205. 2009
- Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2). Trials. 10:49-49. 2009
- Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer. New England Journal of Medicine. 349:247-257. 2003